The Patient brings new perspective

Share this article:
Wolters Kluwer is launching The Patient, a quarterly journal that will look at reimbursement issues from a patient perspective.

“We're trying to change the world from one that says ‘no' to medical innovation to one that says, ‘Well, what does the patient think?'” says editor John F. P. Bridges, PhD, of Johns Hopkins Bloomberg School of Public Health. Bridges says formularies, governments and others making decisions about drug access need to break out of the cost-effectiveness model as an exclusive means of determining the value of a medication. The title, intended to complement PharmacoEconomics, will launch in the fourth quarter.

Share this article:

Email Newsletters

More in News

Sales of Biogen MS pill pick up overseas

Sales of Biogen MS pill pick up overseas

Biogen Idec is seeing strong sales for blockbuster MS drug Tecfidera, especially overseas where it's beginning to catch fire this summer.

GSK second-quarter sales disappoint

GSK second-quarter sales disappoint

Executives urge analysts to focus on the company's long-term potential.

House bill would speed approval once EU OKs same product

House bill would speed approval once EU OKs ...

The Speeding Access to Already Approved Pharmaceuticals Act of 2014 would require FDA to expedite the review of pharmaceuticals that are already approved by the European Union